APA (7th ed.) Citation

Vloten, J. P. v., Matuszewska, K., Minow, M. A. A., Minott, J. A., Santry, L. A., Pereira, M., . . . Wootton, S. K. (2022). Oncolytic Orf virus licenses NK cells via cDC1 to activate innate and adaptive antitumor mechanisms and extends survival in a murine model of late-stage ovarian cancer. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Vloten, Jacob P van, et al. Oncolytic Orf Virus Licenses NK Cells via CDC1 to Activate Innate and Adaptive Antitumor Mechanisms and Extends Survival in a Murine Model of Late-stage Ovarian Cancer. BMJ Publishing Group, 2022.

MLA (9th ed.) Citation

Vloten, Jacob P van, et al. Oncolytic Orf Virus Licenses NK Cells via CDC1 to Activate Innate and Adaptive Antitumor Mechanisms and Extends Survival in a Murine Model of Late-stage Ovarian Cancer. BMJ Publishing Group, 2022.